5 Biotech Stocks That More Than Doubled This Year
It has been an eventful year for the volatile biotech sector, which has been in the spotlight from the onset of 2020, owing to the coronavirus outbreak. The Nasdaq Biotechnology Index witnessed a roller coaster ... [Read]
ETFs to Tap AstraZeneca Mega-Deal to Buy Alexion
The biotech sector has been buzzing hot amid the COVID-19 vaccine rollout and mega-merger activity. British pharmaceutical company AstraZeneca plc AZN has agreed to buy rare-disease specialist Alexion Pharmaceuticals ALXN for $39 billion. The deal ... [Read]
Gilead (GILD) to Buy MYR GmbH for EUR1.15 Billion in Cash
Gilead Sciences, Inc . GILD announced that it will acquire a private, commercial stage German biotechnology company MYR GmbH for €1.15 billion in cash, payable upon closing the transaction along with a potential future milestone ... [Read]
Biotech Stock Roundup: ASH Data in Focus, CRIS, BCRX Surge & More Pipeline News
This week, the focus was on data presented at the annual conference of the American Society of Hematology (ASH) from Dec 5 to Dec 8. This apart, the regular pipeline and regulatory updates on the ... [Read]
Reata Pharmaceuticals, Inc. Announces Closing of Class A Common Stock Offering
PLANO, Texas, Dec. 04, 2020 (GLOBE NEWSWIRE) — Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata” or the “Company”), a clinical-stage biopharmaceutical company, today announced the closing of its previously announced underwritten public offering of 2,000,000 shares ... [Read]
Humana (HUM) Gears Up for Q3 Earnings: What Awaits the Stock?
Humana Inc. ’s HUM third-quarter 2020 results are scheduled to be reported on Nov 3, 2020. Factors to Impact Q3 Results The to-be-reported quarter’s earnings results are likely to reflect better revenues. Notably, the consensus ... [Read]
Agios Pharmaceuticals (AGIO) May Report Negative Earnings: Know the Trend Ahead of Next Week’s Release
The market expects Agios Pharmaceuticals (AGIO) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2020. This widely-known consensus outlook is important in assessing the ... [Read]
CRISPR (CRSP) Falls Despite Positive Data on Lymphoma Study
CRISPR Therapeutics AG CRSP announced top-line data from an early-stage study, which is evaluating several dose levels of its allogeneic chimeric antigen receptor T cell (CAR-T) cell therapy CTX110 for treating relapse/refractory CD19+ B-cell malignancies. ... [Read]
New Ventures Funds Rebrands as Scientia Ventures
NEW-VENTURES-rebrands PR Newswire NEW YORK, Oct. 2, 2020 NEW YORK , Oct. 2, 2020 /PRNewswire/ — New Ventures Funds has launched a new corporate brand identity and changed its name to Scientia Ventures. The new ... [Read]
Ascendis Pharma A/S Announces Participation at the 18th Annual Morgan Stanley Virtual Global Healthcare Conference
COPENHAGEN, Denmark, Sept. 11, 2020 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to address unmet medical needs, today announced that the company will participate in ... [Read]